Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

Good morning, Boston. Here are the five things you need to know in local business news to start your busy Thursday.

Atrial fibrillation is a key risk factor for ischaemic stroke. Furthermore, patients with atrial fibrillation and stroke tend ...

The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...

As for the cardiac arrhythmias observed in 10 of the participants, they included atrial fibrillation (abnormal beating in the ...

BTIG raised the firm’s price target on Boston Scientific (BSX) to $97 from $93 and keeps a Buy rating on the shares. The firm notes that ...

Boston Scientific stock pulled back from its run at a record high on Wednesday despite reporting a sweeping third-quarter beat.

Boston Scientific (BSX) raised its 2024 guidance on Wednesday after logging stronger-than-expected growth in third-quarter results. The medical device maker now expects full-year reported revenue ...